Indicators and predictors of response to anti-viral therapy in chronic hepatitis C
Author:
Open Access
- 28 February 2003
- journal article
- review article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 17 (5) , 611-621
Abstract
No abstract availableKeywords
This publication has 78 references indexed in Scilit:
- National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C: 2002—June 10-12, 2002Hepatology, 2002
- Peginterferon alfa-2A (40 KD) (PEGASYS) in combination with ribavirin (RBV): efficacy and safety results from a phase III, randomized, double-blind, multicentre study examining effect of duration of treatment and RBV doseJournal of Hepatology, 2002
- EASL International Consensus Conference on Hepatitis C Paris, 26–28 February 1999Journal of Hepatology, 1999
- Time course of histological changes in patients with a sustained biochemical and virological response to interferon-α therapy for chronic hepatitis C virus infectionJournal of Hepatology, 1997
- An Algorithm for the Grading of Activity in Chronic Hepatitis CHepatology, 1996
- Histological grading and staging of chronic hepatitisJournal of Hepatology, 1995
- Classification of chronic viral hepatitis: a need for reassessmentJournal of Hepatology, 1991
- Treatment of Chronic Hepatitis C with Recombinant Interferon AlfaNew England Journal of Medicine, 1989
- Treatment of Chronic Non-A, Non-B Hepatitis with Recombinant Human Alpha InterferonNew England Journal of Medicine, 1986
- Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis†Hepatology, 1981